LYN and B-cell chronic lymphocytic leukemia: Also; Gattazzo et al., (2012) suggested that cortactin is involved in aggressiveness and spreading of B-CLL cells and that Lyn-cortactin axis could represent an alternative target for the development of new therapeutic strategies.